Irish study gives cystic fibrosis hope

A new Irish-led approach to treating cystic fibrosis (CF) reduces inflammation, potentially reducing the need for lung transplants and lowering the risk of death.

The study, led by researchers at the Royal College of Surgeons in Ireland (RCSI), has been published in the American Journal of Respiratory and Critical Care Medicine.